Patterson, K ;
Prabhu, V ;
Xu, RF...
Patterson , K , Prabhu , V , Xu , RF , Li , HJ , Meng , Y , Zarabi , N , Zhong , YC , Batteson , R , Pellissier , J , Keefe , S , Grivas , P & de Wit , R 2019 , ' Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy ' , European urology oncology , vol. 2 , no. 5 , pp. 565-571 . https://doi.org/10.1016/j.euo.2018.09.009.
,
2019